Grifols | GRFS - Trade Creditors


Grifols reported EUR987.75M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 400K 213K Mar/2026
Arca Biopharma USD 6.67M 2.5M Mar/2026
aTyr Pharma USD 3.24M 487K Jun/2026
Bio Path USD 5.16M 260K Mar/2026
Brainstorm Cell Therapeutics USD 7.49M 171K Jun/2026
Capricor Therapeutics 3.08M 848.23K Jun/2026
Cara Therapeutics USD 4.62M 1.4M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Grifols EUR 987.75M 47.87M Dec/2025
Immunic USD 11.01M 873K Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Nektar Therapeutics USD 10.03M 744K Mar/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
TherapeuticsMD USD 143K 4K Jun/2024